美股市場個股詳情
DXCM 德康醫療
- 80.040
- +4.220+5.57%
收盤價 12/20 16:00 (美東)
- 80.040
- 0.0000.00%
盤後 20:01 (美東)
312.63億總市值48.51市盈率TTM
81.510最高價75.470最低價1157.85萬股成交量75.470今開75.820昨收9.23億成交額2.99%換手率61.57市盈率(靜)3.91億總股本142.00052周最高15.80市淨率310.31億流通值62.34052周最低--股息TTM3.88億流通股164.863歷史最高--股息率TTM7.97%振幅0.340歷史最低79.717平均價1股每手
關於德康醫療公司
德康醫療公司爲糖尿病患者設計並商業化連續血糖監測（CGM）系統。連續血糖監測系統可作爲傳統血糖儀工藝的替代方案，該公司正在發展其連續血糖監測系統，以提供與胰島素泵的集成，以實現胰島素的自動輸送。
公司介紹
公司代碼DXCM
公司名稱德康醫療
上市日期2005/04/14
發行價格12.00
成立日期1999
CEOMr. Terrance H. Gregg
所屬市場納斯達克
員工數量9600
年結日12-31
公司地址6340 Sequence Drive
城市San Diego
省份加利福尼亞州
國家美國
郵編92121
電話1-858-200-0200
董事高管
- 姓名
- 職務
- 年薪
- Kevin R. Sayer, C.P.A.
- President, Chief Executive Officer and Chairman of the Board
- 1571.22萬
- Teri L Lawver
- Executive Vice President and Chief Commercial Officer
- 652.66萬
- Sadie Stern
- Executive Vice President and Chief Human Resources Officer
- --
- Jake Leach
- Executive Vice President and Chief Operating Officer
- 493.80萬
- Jereme M. Sylvain
- Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- 425.49萬
- Michael Brown
- Executive Vice President and Chief Legal Officer
- 434.28萬
- Matthew Vincent Dolan
- Executive Vice President, Strategy, Corporate Development and Dexcom Labs
- --
- Kyle Malady
- Independent Director
- 34.34萬
- Professor Dr. Eric J. Topol, M.D.
- Independent Director
- 34.65萬
- Karen M. Dahut
- Independent Director
- 34.59萬
- Nicholas Augustinos
- Independent Director
- 36.22萬
- Richard A. Collins
- Independent Director
- 34.59萬
- Rimma Driscoll
- Independent Director
- 40.47萬
- Bridgette P. Heller
- Independent Director
- 34.65萬
- Mark G. Foletta
- Lead Independent Director
- 39.35萬
- Steven R. Altman
- Independent Director
- 34.34萬
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據
